Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
doi: 10.1038/ni.1863 47 BlasiusALBeutlerB
In addition, we do not see the same magnitude of cardiovascular risk reduction from equivalent weight loss from calorie restriction. In a published expert reaction to the SELECT trial, Tricia Tan, consultant in diabetes, endocrinology and metabolic medicine at Imperial College London and NHS Trust, highlighted the subsequent implication for National Institute for Health and Care Excellence (NICE) guidance, which currently recommends stopping semaglutide treatment in patients who have not lost more than 5% of weight after six months
The drug, manufactured by Danish firm Novo Nordisk, is delivered via a weekly injection and has been hailed a game changer in the battle against obesity
Our provider team has helped thousands of patients to reach their goals and live a healthier life
Stephan RP, Reilly CR, Witte PL
US$ 28.64
US$ 25.81
US$ 28.76
US$ 22.18
US$ 28.12
US$ 24.16
